Literature DB >> 11964541

The utility of inhibitory quotients in determining the relative potency of protease inhibitors.

Peter J Piliero.   

Abstract

Mesh:

Substances:

Year:  2002        PMID: 11964541     DOI: 10.1097/00002030-200203290-00020

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  6 in total

Review 1.  Clinical pharmacokinetics and summary of efficacy and tolerability of atazanavir.

Authors:  Clotilde Le Tiec; Aurélie Barrail; Cécile Goujard; Anne-Marie Taburet
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

2.  Differential protein binding of indinavir and saquinavir in matched maternal and umbilical cord plasma.

Authors:  Sreeja Sudhakaran; Craig R Rayner; Jian Li; David C M Kong; Neil M Gude; Roger L Nation
Journal:  Br J Clin Pharmacol       Date:  2006-09-19       Impact factor: 4.335

Review 3.  Therapeutic drug monitoring: an aid to optimising response to antiretroviral drugs?

Authors:  Rob E Aarnoutse; Jonathan M Schapiro; Charles A B Boucher; Yechiel A Hekster; David M Burger
Journal:  Drugs       Date:  2003       Impact factor: 9.546

4.  Predictive values of the human immunodeficiency virus phenotype and genotype and of amprenavir and lopinavir inhibitory quotients in heavily pretreated patients on a ritonavir-boosted dual-protease-inhibitor regimen.

Authors:  Aurélie Barrail-Tran; Laurence Morand-Joubert; Gwendoline Poizat; Gilles Raguin; Clotilde Le Tiec; François Clavel; Elisabeth Dam; Geneviève Chêne; Pierre-Marie Girard; Anne-Marie Taburet
Journal:  Antimicrob Agents Chemother       Date:  2008-02-19       Impact factor: 5.191

5.  Estimation of serum-free 50-percent inhibitory concentrations for human immunodeficiency virus protease inhibitors lopinavir and ritonavir.

Authors:  Dean Hickman; Sudthida Vasavanonda; George Nequist; Lynn Colletti; Warren M Kati; Richard Bertz; Ann Hsu; Dale J Kempf
Journal:  Antimicrob Agents Chemother       Date:  2004-08       Impact factor: 5.191

6.  Novel single-cell-level phenotypic assay for residual drug susceptibility and reduced replication capacity of drug-resistant human immunodeficiency virus type 1.

Authors:  Haili Zhang; Yan Zhou; Cecily Alcock; Tara Kiefer; Daphne Monie; Janet Siliciano; Quan Li; Paul Pham; Joseph Cofrancesco; Deborah Persaud; Robert F Siliciano
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.